tiprankstipranks
TransCode Therapeutics (RNAZ)
NASDAQ:RNAZ
US Market

TransCode Therapeutics (RNAZ) Stock Investors

Compare
309 Followers
Based on 789,703 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold RNAZ
On average, investors allocate 0.00% of their portfolios to RNAZ
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 789,703 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding RNAZ

4.7%
Last 7
Days
8.9%
Last 30
Days
Percentages indicate the change in the number of portfolios holding RNAZ, out of 789,703 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

RNAZ Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
0.01%
$24.39
Based on the activity of investors who made their portfolios public
The table shows changes in RNAZ in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

RNAZ Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Plug Power
4.99%
-0.88%
-1.86%
1.55B
Industrials
Lucid Group
5.43%
+0.59%
+1.31%
9.22B
Consumer Cyclical
Viking Therapeutics
3.85%
-0.67%
-2.33%
3.24B
Healthcare
Riot Platforms
4.71%
-0.51%
-3.81%
3.60B
Financial
DraftKings
4.91%
+0.45%
+0.49%
40.24B
Consumer Cyclical
Nio
9.06%
-0.56%
-1.06%
9.86B
Consumer Cyclical
Marathon Digital Holdings
5.02%
+0.24%
-1.37%
4.72B
Financial
Airbnb
4.07%
-0.74%
+1.81%
92.10B
Consumer Cyclical
Truth Social
4.90%
-1.00%
-4.37%
5.24B
Financial
BigBearai Holdings
4.50%
+2.59%
+34.19%
1.30B
Technology
Based on the activity of 789,703 active portfolios
Open your Smart Portfolio

RNAZ Investor Analysis

RNAZ investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
41.2%
of RNAZ holders
are under 35
Average Segment Performance
Average P/E Ratio32.07
Beta10.89
Dividend Yield3.86%
RNAZ investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
29.4%
of RNAZ holders
are between 35–55
Average Segment Performance
Average P/E Ratio31.21
Beta20.94
Dividend Yield3.32%
RNAZ investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
29.4%
of RNAZ holders
are over 55
Average Segment Performance
Average P/E Ratio30.83
Beta10.47
Dividend Yield3.57%
Overview of age group and performance of RNAZ stock investors
See who invests in RNAZ according to age group and performance.

FAQ

How many retail Investors hold RNAZ?
<0.1% of TipRanks' retail investors hold RNAZ in their portfolios.
    What is RNAZ Investor Sentiment?
    RNAZ’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of RNAZ in the last 7 days?
      ▼ 4.7% of TipRanks' retail investors changed their holding of RNAZ in the last 7 days.
        What percentage of retail investors changed their holding of RNAZ in the last 30 days?
        ▼ 8.9% of TipRanks' retail investors changed their holding of RNAZ in the last 30 days.
          What is the average age of retail investors who hold RNAZ?
          The average age of RNAZ Holders is under 35.
            What other stocks have RNAZ investors also bought?
            RNAZ Investors also bought PLUG, LCID, VKTX, RIOT, DKNG, NIO, MARA, ABNB, DJT, BBAI.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              ALGNAlign Tech
              AZNAstraZeneca
              BMYBristol-Myers Squibb
              CNCCentene
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis